A detailed history of Northwest Financial Advisors transactions in Amgen Inc stock. As of the latest transaction made, Northwest Financial Advisors holds 211 shares of AMGN stock, worth $62,034. This represents 0.05% of its overall portfolio holdings.

Number of Shares
211
Previous 242 12.81%
Holding current value
$62,034
Previous $75.6 Million 10.09%
% of portfolio
0.05%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$309.38 - $337.38 $9,590 - $10,458
-31 Reduced 12.81%
211 $68 Million
Q2 2024

Aug 12, 2024

SELL
$262.75 - $319.31 $4,204 - $5,108
-16 Reduced 6.2%
242 $75.6 Million
Q1 2024

May 09, 2024

SELL
$268.87 - $324.56 $5,646 - $6,815
-21 Reduced 7.53%
258 $73.4 Million
Q4 2023

Feb 07, 2024

BUY
$255.7 - $288.46 $71,340 - $80,480
279 New
279 $80.4 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Northwest Financial Advisors Portfolio

Follow Northwest Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Financial Advisors with notifications on news.